Table 3.

Summary of prior treatments in enrolled subjects

Subject Number	Prior Treatment Summary
101	Right Hepatectomy
102	TACE (Cisplatin) : 3X
201	Liver Resection;
	Radiofrequency Ablation;
	Doxorubicin: 6 cycles;
	TACE (Cisplatin): 2X;
	Anti-VEGF: 6 cycles
202	Right Hepatectomy;
	Doxorubicin: 6 cycles;
	Anti-VEGF: 6 cycles
203	Sorafenib: 8 cycles;
	Capecitabine: 8 cycles;
	Oxaliplatin: 8 cycles;
	TACE (Cisplatin): 4X
301	TACE (Cisplatin): 4X;
	Anti-VEGF: 9 cycles
302	Anti-VEGF: 4 cycles
403	Hepatectomy;
	Anti-VEGF: 2 cycles
	TACE (Cisplatin): 8X
405	Doxorubicin: 3 cycles;
	Anti-VEGF: 14 cycles;
	TACE (Cisplatin) : 8X
406	Hepatectomy only

TACE Transarterial chemo-embolization; Anti-VEGF Anti vascular endothelial growth factor